Prevalence and clinical features of cryoglobulinaemia in multitransfused β-thalassaemia patients

Annals of the Rheumatic Diseases

Volumn 58, Issue 11, 1999, Pages 698-702

  Perniola, R ^a,b   De Rinaldis, C ^a   Accogli, E ^a   Lobreglio, G ^a  

^a VITO FAZZI HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; PREVALENCE; PRIORITY JOURNAL; VIREMIA;

EID: 0032744187     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.11.698     Document Type: Article

References (35)

1. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990;46:423-41.
2. Lai ME, De Virgilis S, Argiolu F, Farei P, Mazzoleni AP, Lisci V, et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first-and second-generation assay. J Pediatr Gastroenterol Nutr 1993;16:458-64.
3. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123:615-20.
4. Ábel G, Zhang Q-X, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993;36:1341-9.
5. Motulsky H. Initiative biostatistics, New York: Oxford University Press, 1995:297-302.
6. Economidou J, Pathouli C, Hadzivannis S, Fostiropoulos G, Constantoulakis M. Complement levels in relation to certain antibodies in polytransfused thalassaemic patients. Vox Sang 1976;31 (suppl 1):32-8.
7. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996;24:1338-41.
8. Akriviadis EA, Xanthakis I, Navrozidou C, Papadopoulos A. Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-α. J Clin Gastroenterol 1997;25:612-18.
9. Fayyazi A, Schott P, Hartmann H, Mihm S, Middel P, Ramadori G, et al. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia. Z Gastroenterol 1997;35:921-8.
10. Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripods M-F, et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996;28:1-9.
11. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux J-M, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996;25:427-32.
12. Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A. Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr 1992;151:573-6.
13. Sirchia G, Almini D, Bellobuono A, Giovanetti AM, Marconi M, Mercuriali F, et al. Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sang 1990;59:26-9.
14. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996;124:31-4.
15. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N, Cryoglobulinemia - A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966;40:837-56.
16. Brouet J-C, Clauvel J-P, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 case. Am J Med 1974;57:775-88.
17. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
18. Ferri C, Greco F, Longobardo G, Palla P, Moretti A, Marzo E, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:621-4.
19. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med 1995;88:115-26.
20. Wong VS, Egner W, Elsey T, Brown D, Alexander GJM. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996;104:25-31.
21. Kerr GS, Rofail M, Lewis JH, Kumar P, Seeff LB. Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital. J Rheumatol 1997;24:2134-8.
22. Lee YH, Ji JD, Yeon JE, Byun KS, Lee CH, Song GG. Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis 1998;57:728-31.
23. Agnello V. Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective. Hepatology 1997;26:1375-9.
24. Page EH, Shear NH. Temperature-dependent skin disorders. J Am Acad Dermatol 1988;18:1003-1019.
25. Orvieto R, Leichrer I, Rachmilewitz EA, Margulies JY. Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusion, and treatment with desferrioxamine. Calcif Tissue Int 1992;50:397-9.
26. Anapliotou MLG, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P. The contribution of hypogonadism to the development of osteoporosis in thalassaerma major: new therapeutic approaches. Clin Endocrinol (Oxf) 1995;42:279-87.
27. Al-Refaie FN, Hershko C, Hoffbrand AV, Kosaryan M, Olivieri NF, Tondury P, et al. Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators. Br J Haematol 1995;91:224-9.
28. Shapira Y, Glick B, Finsterbush A, Goldfarb A, Rosenmann E. Myopathological findings in thalassemia major. Eur Neurol 1990;30:324-7.
29. Sher GD, Olivieri NF. Rapid healing of chronic leg ulcers during arginine butyrate therapy in patients with sickle cell disease and thalassemia. Blood 1994;84:2378-80.
30. Michelakakis H, Dimitriou E, Georgakis H, Karabatsos F, Fragodimitri C, Saraphidou J, et al. Iron overload and urinary lysosomal enzyme levels in β-rhalassaemia major. Eur J Pediatr 1997;156:602-4.
31. Cianciulli P, Sollecito D, Sorrentino F, Forte L, Gilardi E, Massa A, et al. Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy. Kidney Int 1994;46:467-70.
32. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995;25:361-9.
33. Ferri C, La Civita L, Cirafisi C, Siciliano G, Longobardo G, Bombardiers S, et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 1992;19:889-95.
34. Papavasiliou C. Clinical expressions of the expansion of the bone marrow in the chronic anemias: the role of radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:605-12.
35. Papavasiliou C, Gouliamos A, Vlahos L, Trakadas S, Kalovidouris A, Pouliades G. CT and MRI of symptomatic spinal involvement by extramedullary haemopoiesis. Clin Radiol 1990;42:91-2.